Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and ...
Zacks.com on MSN18h
FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib (Revised)
If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability ...
Indiatimes3h
Graviss Hospitality Share Price
Graviss Hospitality Ltd., incorporated in the year 1959, is a Small Cap company (having a market cap of Rs 301.82 Crore) operating in Tourism & Hospitality sector. Graviss Hospitality Ltd. key ...